Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Consolidated Net Profit

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹66 Cr₹61 Cr₹58 Cr₹43 Cr₹38 Cr

What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?

The latest Consolidated Net Profit ratio of WINDLAS BIOTECH is ₹66 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹66 Cr
Mar2025₹61 Cr
Mar2024₹58 Cr
Mar2023₹43 Cr
Mar2022₹38 Cr

How is Consolidated Net Profit of WINDLAS BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹66 Cr
8.95
Mar2025 ₹61 Cr
4.82
Mar2024 ₹58 Cr
36.51
Mar2023 ₹43 Cr
11.91
Mar2022 ₹38 Cr -

Compare Consolidated Net Profit of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,769.4 Cr 0.1% 6% -2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,005.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹163,246.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹118,854.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹114,246.0 Cr 0.9% 8% 5.6% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

0.1%

6%

-2.2%

SENSEX

2%

5.3%

-6.5%


You may also like the below Video Courses